Infectious Diseases Society of America

Nonprofit profile at a glance

EIN
237045686
IRS 990 coverage
2010–2024
Official website data refreshed
Sep 2026
Forms available
Form 990 2024
Location
Arlington, VA, USA
Phone
(703) 299-0200
Rating confidence
Limited

Official website

Reported finances

Revenue
$32,259,941
Expenses
$39,521,191
Assets
$66,284,980
Liabilities
$17,232,049

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

28 people listed

Executive titles in this filing

  • CHRISTOPHER BUSKY CAE (CHIEF EXECUTIVE OFFICER)
  • STEVEN K SCHMITT MD (IMMED. PAST PRESIDENT AS OF 10/2024)
  • TINA Q TAN MD (PRESIDENT AS OF 10/2024)
  • CARLOS DEL RIO MD (IMMED. PAST PRESIDENT UNTIL 10/2024)
  • RONALD NAHASS MD (PRESIDENT ELECT AS OF 10/2024)
  • WENDY S ARMSTRONG MD (VICE PRESIDENT AS OF 10/2024)

Highest reported compensation

  • CHRISTOPHER BUSKY CAE (CHIEF EXECUTIVE OFFICER): $813,135 total reported compensation
  • TY JOHNSON (CHIEF OPERATING OFFICER): $470,589 total reported compensation
  • DANA WOLLINS (SVP, STRATEGY): $344,657 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The Infectious Diseases Society of America (IDSA) is a professional medical society representing physicians, scientists, and other healthcare professionals dedicated to improving the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and advocacy relating to infectious diseases.

What it reported doing in 2024

Clinical infectious diseases (cid), the journal of infectious diseases (jid) and open forum infectious diseases (ofid) are scholarly journals published by idsa in partnership with an outside publisher to disseminate the latest research on a variety of topics in the field to members and subscribers. Cid publishes original research, reviews and perspectives that all clinicians can use when caring for patients. Cid covers the clinical presentation, diagnosis, treatment and prevention of the full range of infectious diseases. The evaluation of current and novel treatments, microbiology, immunology and policies as they relate to patient care are highly prioritized. Published continuously since 1904, jid is the premier global journal for translational infectious diseases science. The editors welcome major articles and brief reports describing research results on microbiology, immunology, epidemiology, and related disciplines, on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune responses. Ofid publishes clinical, translational and basic research in a fully open access, online journal. It focuses on the intersection of biomedical science and clinical practice, with an emphasis on knowledge that could improve patient care globally. Articles are written by experts in the field, including members and non-members, and reviewed by a panel of leading medical experts before they are published.

Operating model

Revenue model
Other-operating. 91% of the money available for current operations came from other operating revenue.
Distribution model
Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: NotEnoughData
  • Transparency & Controls: 78
  • Accountability: 95
  • Sustainability: 26
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: Limited
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
  • Pay-setting controls: 4 of 6 controls in place; rating input score 67
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Pass
    • Written employment contract: Pass
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: 1 of 8 controls in place; rating input score 12
    • Claims monitoring procedures: Pass
    • Requires narrative reports: Limited
    • Conducts field audits: Limited
    • May suspend future funding: Limited
    • Requires financial reports: Limited
    • Conducts site visits: Limited
    • Requires grant agreements: Limited
    • May require repayment: Limited
  • Grant itemization coverage: 100%; rating input score 100; 72nd percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 66th percentile among comparable filings
  • Governance controls: 8 of 9 controls in place; rating input score 89
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Pass
    • Other executive compensation review process: Fail
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: -22.5%; rating input score 4; 4th percentile among comparable filings
  • Total-asset coverage ratio: 1.68; rating input score 55; 55th percentile among comparable filings
  • Liabilities to assets ratio: 0.26; rating input score 51; 51st percentile among comparable filings
  • Officer compensation ratio: 9.9%; rating input score 20; 20th percentile among comparable filings

Growth

  • Program expense growth: Limited
  • Revenue growth: 6.8% per year; rating input score 100; 58th percentile among comparable filings
  • Asset growth: 7.3% per year; rating input score 100; 51st percentile among comparable filings

Details

  • What they do: 1 operating location identified
  • Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
  • Governance: 15 of 15 board members independent · 8 of 9 filing controls reported
  • Programs: 4 filed program accomplishments
  • Leadership: top reported pay $813K · 28 people listed · 4 of 6 pay-setting controls reported
  • Highest-paid contractors: 5 contractors listed · $916K reported
  • Consistency: 16 of 16 current checks pass
  • Schedules: 8 filed schedules · includes major donors, foreign activity, grants, and executive pay
  • Filing history: 14 filing years from 2010 to 2024
  • Contacts: How to reach this organization
  • Money network: 15 filed money-flow records
  • Related organizations: 2 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Sustainability: Operating margin scored 4/100.
  • Review — Accountability: Governance controls: Other executive compensation review process not reported.
  • Review — Sustainability: Total-asset coverage ratio scored 55/100.
  • High — Sustainability: Officer compensation ratio scored 20/100.
  • Review — Sustainability: Liabilities to assets ratio scored 51/100.